ABCB1 and major depressive disorder: In a clinical trial with MDD, Schatzberg, and DeBattista [30] found that one SNP from the ABCB1 gene had a significant effect on remission rates and side effects frequency in patients treated with escitalopram, sertraline or venlafaxine.